TNF and COVID-19: Interestingly, serum TNF levels in patients with COVID-19 were significantly higher, which was positively correlated with disease severity and death (Del Valle et al., 2020), and the hospitalization rate of COVID-19 patients treated with TNF inhibitors was lower (Gianfrancesco et al., 2020), suggesting that TNF inhibitors have potential for the treatment of COVID-19.